Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy.

Suppr

超能文献

作者信息

Hedner U, Glazer S, Pingel K, Alberts K A, Blombäck M, Schulman S, Johnsson H

出版信息

Lancet. 1988 Nov 19;2(8621):1193. doi: 10.1016/s0140-6736(88)90259-0.

DOI:10.1016/s0140-6736(88)90259-0

PMID:2903400

Abstract

摘要

相似文献

Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy.

Lancet. 1988 Nov 19;2(8621):1193. doi: 10.1016/s0140-6736(88)90259-0.

Recombinant factor VIIa (r-FVIIa) in haemophilia management.重组凝血因子VIIa（r-FVIIa）在血友病治疗中的应用。

Transfus Sci. 1996 Sep;17(3):339-40. doi: 10.1016/0955-3886(96)00039-2.

Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors.血友病伴抑制物患者预防性使用重组凝血因子VIIa。

Haemophilia. 2005 May;11(3):203-7. doi: 10.1111/j.1365-2516.2005.01096.x.

Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report.重组活化凝血因子 VII（rFVIIa）用于血友病 A 伴抑制剂患者的长期二级预防：一例报告

Thromb Haemost. 2010 Apr;103(4):868-70. doi: 10.1160/TH09-10-0709. Epub 2010 Feb 2.

Trial of haemophilia treatment for intracerebral haemorrhage.脑出血血友病治疗试验。

Lancet Neurol. 2004 Aug;3(8):448. doi: 10.1016/s1474-4422(04)00834-8.

Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.重组凝血因子VIIa对严重先天性凝血因子VII缺乏症患者的预防作用

Haemophilia. 2004 May;10(3):295-8. doi: 10.1111/j.1365-2516.2004.00885.x.

The use of activated recombinant coagulation factor VII during haemarthroses and synovectomy in a patient with congenital severe factor V deficiency.先天性严重因子V缺乏患者在关节积血和滑膜切除术中使用活化重组凝血因子VII。

Haemophilia. 2005 Mar;11(2):167-70. doi: 10.1111/j.1365-2516.2005.00956.x.

Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.

Haematologica. 2004 Jun;89(6):759-61.

Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII.

Thromb Haemost. 2002 Oct;88(4):698-9.

Case report on recombinant coagulation factor VIIa in the treatment of three haemophilia A patients with inhibitors in Singapore.新加坡重组凝血因子VIIa治疗三名甲型血友病伴抑制物患者的病例报告。

Ann Acad Med Singap. 2002 Mar;31(2):241-4.

引用本文的文献

The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.在成人和儿科血友病伴有抑制物的患者中，使用活化eptacog beta 治疗出血发作和围手术期止血的安全性。

Haemophilia. 2021 Nov;27(6):921-931. doi: 10.1111/hae.14419. Epub 2021 Oct 11.

Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.凝血因子 VII 的生化、分子和临床方面及其在止血和血栓形成中的作用。

Haematologica. 2021 Feb 1;106(2):351-362. doi: 10.3324/haematol.2020.248542.

Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date.重组人凝血因子VIIa（rFVIIa）在血友病中的作用机制及目前的证据。

Ther Adv Hematol. 2017 Dec;8(12):345-352. doi: 10.1177/2040620717737701. Epub 2017 Nov 3.

The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitors.重组活化因子 VII 在有抑制剂的血友病 A 患者择期骨科手术血液管理中的作用。

Blood Transfus. 2017 Sep;15(5):478-486. doi: 10.2450/2017.0369-16. Epub 2017 May 16.

Recombinant Factor VIIa Use for Endoscopic Retrograde Cholangiopancreatography With Sphincterotomy in a Patient With Choledocholithiasis and Unusual Coagulopathy.重组凝血因子VIIa在一名患有胆总管结石和特殊凝血障碍的患者行内镜逆行胰胆管造影术并括约肌切开术中的应用

Gastroenterology Res. 2017 Apr;10(2):144-146. doi: 10.14740/gr812w. Epub 2017 Apr 19.

Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.血友病抑制物患者的成就、挑战与未满足需求：2014年11月20日于法国巴黎召开的研讨会报告

Haemophilia. 2016 Jan;22 Suppl 1(Suppl 1):1-24. doi: 10.1111/hae.12860.

Correction of knee flexion contracture at the time of surgical fixation of a femoral supracondylar fracture in a haemophiliac with inhibitors.在一名患有抑制剂的血友病患者股骨髁上骨折手术固定时矫正膝关节屈曲挛缩。

Blood Transfus. 2015 Apr;13(2):333-5. doi: 10.2450/2014.0149-14. Epub 2014 Oct 23.

Recombinant activated factor VII in clinical practice: a 2014 update.重组活化凝血因子 VII 在临床实践中的应用：2014 年更新版

J Thromb Thrombolysis. 2015 Feb;39(2):235-40. doi: 10.1007/s11239-014-1114-1.

Tissue factor controversies.组织因子争议。

Thromb Res. 2012 May;129 Suppl 2(Suppl 2):S5-7. doi: 10.1016/j.thromres.2012.02.018. Epub 2012 Mar 7.

Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors.重组活化凝血因子VII在治疗伴有凝血因子抑制物的血友病患者中作用的批判性评价

J Blood Med. 2010;1:37-48. doi: 10.2147/JBM.S6209. Epub 2010 Mar 30.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验